REQUIREMENTS

Applicants must be residing and working in one of the following countries:

• Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Canada, Colombia, Czech Republic, Denmark, Egypt, Finland, Germany, Greece, Hungary, Iceland, India, Iraq, Israel, Italy, Japan, Kuwait, Mexico, Morocco, The Netherlands, Norway, Oman, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Taiwan, Tunisia, Ukraine,  the United Arab Emirates, United States of America.
• For Pompe disease, submissions from China will also be eligible.

Applicants must be individuals working for a healthcare organization duly incorporated and registered in a country belonging to the list of countries mentioned in the previous paragraph.

In some countries, only individuals working for non-profit healthcare organizations are eligible to apply for the 2024 Medical Award in ASMD and Pompe Disease (e.g. Canada).

Applications for the 2024 Medical Award in ASMD and Pompe disease must be completed in full:

1. Submission of curriculum vitae (CV) including your place of work and specialty
2. Submission of an abstract (max. 500 words) describing your work using the template provided:
   • Title
   • Author(s) with affiliation(s)
   • Background
   • Objective
   • Methods
   • Results
   • Conclusions
   • Statement regarding novelty

Abstract for a 2024 Medical Award in ASMD:

The abstracts of cases/case series in ASMD providing insights into any of the following topics are eligible for submission:

• Clinical manifestations
• Natural history
• Novel diagnostic or monitoring approaches including biomarkers
• Diagnostic challenges (including missed or delayed diagnosis, (sub)population screening)
• Genotype phenotype correlation
• Novel variants
• Patient stratification
• Disease management (including transplantation and treatment)
• Patient Reported Outcomes (PROs)

Abstract for a 2024 Medical Award in Pompe disease:

The abstracts of cases/case series in Pompe disease providing insights into any of the following topics are eligible for submission:

• Clinical manifestations (submissions describing unusual manifestations are encouraged)
• Natural history
• Novel diagnostic or monitoring approaches including biomarkers
• Diagnostic challenges (including missed or delayed diagnosis)
• Genotype phenotype correlation
• Disease management (including treatment)
• Interface between clinical management and public health issues (e.g., continuing medical education, primary care units, screening)
• Patient Reported Outcomes (PROs)

2024 Applications related to any project that currently receives funding from Sanofi will not be accepted.